Skip to main content
Signal8

Turbogen Ltd. Form 6-K — Sep 24, 2026

Form 6-KFiled Sep 24, 2026, 7:30 AM ET0001213900-26-102839Original filing

TurboGen (NASDAQ: TRBG) reported H1 2026 net loss of $4.2 million, a 45% improvement from $7.6 million a year earlier, driven mainly by a $6.4 million favorable swing in warrant fair-value and debt-extinguishment effects rather than operations. Operating loss more than doubled to $5.2 million from $2.3 million, with R&D up 192% to $1.9 million and G&A up 116% to $3.1 million on share-based compensation and Nasdaq listing costs. The company remains development-stage with zero revenue and does not expect meaningful revenue until end of 2026 at the earliest.

Key figures

Total Assets
8073000
Cash Position
7235000
Shares Outstanding
22561622
Ga expenses
3059000
Rd expenses
1877000
Nasdaq listing date
2026-08-31
Shareholders equity
1629000
Operating loss h1 2025
2261000
Operating loss h1 2026
5217000
Private placement shares
1131616
Sales marketing expenses
281000
Warrants liability june 30 2026
2040000
Private placement price per share usd
4.42
August private placement gross proceeds
5000000

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.